Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Purespring Therapeutics Ltd.
Headquarters: London, United Kingdom
Website: https://purespringtx.com/
Year Founded: 2020
Status: Private
See Emerging Company Profile .
BioCentury | Mar 13, 2025
Management Tracks
Scarlett steps down as CEO of Geron
Plus: Purespring names Haseeb Ahmad CEO, and updates from Cellevate and Moffitt Cancer Center
BioCentury | Oct 11, 2024
Finance
City is location of Maraganore’s next RNAi play
BioCentury’s latest Venture Report includes rounds for Judo, Purespring, Basecamp, Arda and more
BioCentury | May 30, 2024
Product Development
Renal therapies get disease-specific
Endpoint innovation and success stories are driving a surge in renal disease drug development
BioCentury | Feb 22, 2024
Emerging Company Profile
Purespring: treating kidney diseases via podocyte gene therapy platform
From monogenic targets to factories for local protein production, Purespring views podocytes as key to a range of kidney diseases
BioCentury | Sep 7, 2023
Management Tracks
Biogen taps former Genentech exec Grogan as head of research
Plus: Arjona Ferreira named CMO at Organon, and updates from Convergent, Purespring, Nanobiotix, Enzo, FibroGen, Engitix and more
BioCentury | Aug 11, 2023
Discovery & Translation
Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more
BioCentury’s roundup of translational innovations
BioCentury | Nov 21, 2022
Management Tracks
Sandoz’ Francis to take the helm at Teva
Plus: Devey becomes CMO at Quell, and updates from Diadem, Pfizer and more
BioCentury | Sep 7, 2022
Management Tracks
Harpoon’s McMahon becomes CEO at Storm
Plus new CFO, CSO at Voyager and updates from Sonoma, Garuda, Alloy, Homology and more
BioCentury | May 26, 2022
Management Tracks
Ex-Editas CEO Bosley among Advent’s new hires
U.K.-based VC taps Bosley, BioMotiv’s Jindal as it builds U.S. team; hires Syncona’s Schmidt in U.K.
BioCentury | Jan 8, 2021
Management Tracks
PacBio hires pair of Illumina vets; plus Ionis, Sana, Purespring, eFFECTOR, Constellation, T2, MiNA, Vividion, Pharma Two B and WIB
Pacific Biosciences of California Inc. (NASDAQ:PACB) filled two newly created posts via the hiring of a pair of Illumina Inc. (NASDAQ:ILMN) veterans: Mark Van Oene as COO and Peter Fromen as chief
Items per page:
1 - 10 of 10